Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2002
11/27/2002EP1259618A2 Human enzyme molecules
11/27/2002EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259605A2 Mutated cyclin g1 protein
11/27/2002EP1259604A1 Bcmp 84, a protein associated to breast cancer
11/27/2002EP1259603A2 Antisense oligonucleotides of the human chk1 gene and uses thereof
11/27/2002EP1259595A2 Integrin antagonists
11/27/2002EP1259548A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
11/27/2002EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002EP1259536A2 Methods of peptide preparation
11/27/2002EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/27/2002EP1259527A1 35 human secreted proteins
11/27/2002EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
11/27/2002EP1259523A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/27/2002EP1259520A2 Novel purines
11/27/2002EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002EP1259513A2 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
11/27/2002EP1259507A1 Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
11/27/2002EP1259506A1 Pyrazinone thrombin inhibitors
11/27/2002EP1259505A2 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
11/27/2002EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
11/27/2002EP1259502A2 Biologically active analogs of discodermolide
11/27/2002EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
11/27/2002EP1259497A1 Novel quinoline ligands and metal complexes for diagnosis and therapy
11/27/2002EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002EP1259492A1 Substituted piperazine derivatives as mtp inhibitors
11/27/2002EP1259490A2 Synthesis of epothilones, intermediates thereto and analogues thereof
11/27/2002EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002EP1259487A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
11/27/2002EP1259486A1 Pyridine-amidines as modulators of p38 map kinase
11/27/2002EP1259482A2 Sulfur containing compounds
11/27/2002EP1259481A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
11/27/2002EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002EP1259292A2 Therapeutic agents
11/27/2002EP1259262A1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/27/2002EP1259255A1 Pai-2 conjugates for the treatment and imaging of cancer
11/27/2002EP1259248A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d
11/27/2002EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002EP1259245A2 Novel compositions and uses of dictyostatin compounds
11/27/2002EP1259240A2 Agents, such as nicotinamide or cadpr for the treatment of skin disorders
11/27/2002EP1259237A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
11/27/2002EP1259236A1 Tyrosine kinase inhibitors
11/27/2002EP1259235A1 Tyrosine kinase inhibitors
11/27/2002EP1259234A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
11/27/2002EP1259233A1 Modulation of bone formation
11/27/2002EP1259225A2 Liposomes
11/27/2002EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002EP1259125A1 Inulin products with improved nutritional properties
11/27/2002EP1107795B1 Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
11/27/2002EP1059931B1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
11/27/2002EP1028758A4 Methods for treating prostate tumors using radioactive compositions
11/27/2002EP1028757A4 Radioactive embolizing compositions
11/27/2002EP1017672B1 New npy antagonists
11/27/2002EP1000048B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
11/27/2002EP0934331B1 Mirror-symmetrical selection and evolution of nucleic acids
11/27/2002EP0920330B1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
11/27/2002EP0783303B1 Use of aromatic halides for treating mammalian cell proliferation
11/27/2002EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002EP0708648B1 Inhibition of nitric oxide production by retinoic acid
11/27/2002EP0675961B1 Treatment of tumorigenic disease with a modified HSV
11/27/2002CN1382218A 溶瘤腺病毒 Oncolytic adenovirus
11/27/2002CN1382214A Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same
11/27/2002CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002CN1382158A Multiple cytokine-antibody complexes
11/27/2002CN1382157A Therapeutic compounds comprised of anti-FC receptor binding agents
11/27/2002CN1382151A Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382134A Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/27/2002CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002CN1382061A Pharmaceutical compositions for oral and topical administration
11/27/2002CN1382060A Dosages for treatment with anti-ErbB2 antibodies
11/27/2002CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002CN1382050A Oral formulations for anti-tumor compounds
11/27/2002CN1382039A Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate
11/27/2002CN1382038A New and improved formulation for paclitaxel
11/27/2002CN1382036A Solubilized pharmaceutical composition for parenteral administration
11/27/2002CN1381583A Human papillomavirus E6/E7 fusion gene and its efficient expression carrier and fusion protein vaccine
11/27/2002CN1381582A Targetting high-expression recombinant adenovirus of human granulocyte-macrophage colony stimulating factor and its preparing process and usage
11/27/2002CN1381562A Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage
11/27/2002CN1381512A Multi-arm fork type functional polyethylene glycol preparation method and its application in medicine
11/27/2002CN1381501A Tumor necrosis factor inhibiting peptide and its application
11/27/2002CN1381464A Antineoplastic compound intercedenside A
11/27/2002CN1381461A Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application
11/27/2002CN1381266A Tumor pill
11/27/2002CN1381233A Solid disperser of quick-releasing vitamine A acid
11/27/2002CN1094974C Recombined adhenovirus expressing human interleukin 12 and its preparation and use
11/27/2002CN1094973C Recombined adhenovirus expressing human interleukin 18 and its preparation and use
11/27/2002CN1094943C Urethanes and ureas that induce cytokine production
11/27/2002CN1094937C Farnesyltransferase inhibiting quinazolinones
11/26/2002US6486342 Substituted chiral allosteric hemoglobin modifiers
11/26/2002US6486329 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
11/26/2002US6486326 iso-CBI and iso-CI analogs of CC-1065 duocarmycins
11/26/2002US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
1 ... 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 ... 2211